What is Amgen's other current assets?

Amgen (AMGN) reported other current assets of $4.11B in Q1 2026.

How has Amgen's other current assets changed year-over-year?

Amgen's other current assets increased by 26.2% year-over-year, from $3.26B to $4.11B.

What is the long-term trend for Amgen's other current assets?

Over 5 years (2020 to 2025), Amgen's other current assets has grown at a 14.7% compound annual growth rate (CAGR), from $2.08B to $4.13B.

Amgen AMGN Other current assets

Other current assets at other companies

Eli LillyLLY

——

PfizerPFE

——

Nektar TherapeuticsNKTR

——

Rigel PharmaceuticalsRIGL

——

Jazz PharmaceuticalsJAZZ

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$195.44B+34.6%

Enterprise value$252.2B+25.7%

P/E25.1×+3.1×

P/S5.3×+1.1×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's other current assets?: Amgen (AMGN) reported other current assets of $4.11B in Q1 2026.
How has Amgen's other current assets changed year-over-year?: Amgen's other current assets increased by 26.2% year-over-year, from $3.26B to $4.11B.
What is the long-term trend for Amgen's other current assets?: Over 5 years (2020 to 2025), Amgen's other current assets has grown at a 14.7% compound annual growth rate (CAGR), from $2.08B to $4.13B.